Web Analytics
Publications - Pioneering The Molecular Diagnostic Field - Invivoscribe
Publications – Pioneering The Molecular Diagnostic Field2026-07-06T15:11:44-07:00

Publications

Publications

FEATURED PUBLICATIONS

ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid Leukemia

June 3rd, 2026|

VIEW PUBLICATION ⟶

NGS-based MRD monitoring in mature B-cell and plasma cell malignancies. Academia Molecular Biology & Genomics

May 28th, 2026|

VIEW PUBLICATION ⟶

T-cell receptor gamma (TRG) diversity predicts peripheral blood involvement in primary cutaneous T-cell lymphoma

March 5th, 2026|

VIEW PUBLICATION ⟶

Ultrasensitive next-generation sequencing-based clonality assay for disease monitoring in B-cell acute lymphoblastic leukaemia

February 20th, 2026|

VIEW PUBLICATION ⟶

Measurable Residual Disease detection in acute lymphoblastic leukaemia: comparison between targeted NGS and ASO-RQPCR

January 23rd, 2026|

VIEW PUBLICATION ⟶

Measurable residual disease monitoring after hematopoietic stem cell transplantation

December 30th, 2025|

VIEW PUBLICATION ⟶

LATEST PUBLICATIONS

ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid Leukemia

VIEW PUBLICATION ⟶

June 3rd, 2026|

NGS-based MRD monitoring in mature B-cell and plasma cell malignancies. Academia Molecular Biology & Genomics

VIEW PUBLICATION ⟶

May 28th, 2026|

T-cell receptor gamma (TRG) diversity predicts peripheral blood involvement in primary cutaneous T-cell lymphoma

VIEW PUBLICATION ⟶

March 5th, 2026|

Ultrasensitive next-generation sequencing-based clonality assay for disease monitoring in B-cell acute lymphoblastic leukaemia

VIEW PUBLICATION ⟶

February 20th, 2026|

Measurable Residual Disease detection in acute lymphoblastic leukaemia: comparison between targeted NGS and ASO-RQPCR

VIEW PUBLICATION ⟶

January 23rd, 2026|

Measurable residual disease monitoring after hematopoietic stem cell transplantation

VIEW PUBLICATION ⟶

December 30th, 2025|

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia

VIEW PUBLICATION ⟶

November 24th, 2025|

QuANTUM-First: Clinical Validation of the LeukoStrat Companion Diagnostic for the Selection of Patients With Acute Myeloid Leukemia Harboring FMS-Like Tyrosine Kinase 3–Internal Tandem Duplications for Treatment With Quizartinib

VIEW PUBLICATION ⟶

September 3rd, 2025|

A Systematic, Evidence-Based Workflow for Classifying KMT2A Fusions in AML

VIEW PUBLICATION ⟶

July 29th, 2025|

Performance Comparison of Illumina® MiSeq™ and MiSeq™ i100 Systems using Invivoscribe’s LymphoTrack® Assays

VIEW WHITE PAPER ⟶

May 27th, 2025|

From prognostication to precision in acute myeloid leukemia

VIEW PUBLICATION ⟶

May 8th, 2025|

Measurable residual disease and post-transplantation gilteritinib maintenance for patients with FLT3 ITD mutated AML

VIEW PUBLICATION ⟶

May 8th, 2025|

Comparison of Complete Genomics DNBSEQ-G99 Sequencer and Illumina® MiSeqTM using Invivoscribe’s FLT3 ITD MRD Assay and NPM1 MRD Assay

VIEW WHITE PAPER ⟶

November 8th, 2024|

Performance Comparison of Invivoscribe’s LymphoTrack® Assays Between Complete Genomics DNBSEQ-G99 and Illumina® MiSeqTM NGS Platforms

VIEW WHITE PAPER ⟶

November 8th, 2024|

Clonality and Measurable Residual Disease (MRD) Testing on the Illumina NextSeq Sequencers

VIEW WHITE PAPER ⟶

June 21st, 2024|

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

VIEW PUBLICATION ⟶

May 2nd, 2024|

Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing

VIEW PUBLICATION ⟶

March 20th, 2024|

Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal residual disease detection in Chinese patients with multiple myeloma

VIEW PUBLICATION ⟶

March 19th, 2024|

Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing–Based Clonality Testing in B-Cell and Plasma Cell Neoplasms

VIEW PUBLICATION ⟶

March 1st, 2024|

Leveraging Standardized MRD Assays to Guide CLL Treatment

VIEW PUBLICATION ⟶

January 25th, 2024|

Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

VIEW PUBLICATION ⟶

March 23rd, 2023|

DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant

VIEW PUBLICATION ⟶

March 7th, 2023|

Minimal/Measurable Residual Disease (MRD) Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor

VIEW PUBLICATION ⟶

March 2nd, 2023|

Comparing Data Generated Using Multiparametric Flow Cytometry, Capillary Electrophoresis, and Next-Generation Sequencing in a Cohort of B-Cell Lymphoproliferative Disorder Samples

VIEW PUBLICATION ⟶

November 15th, 2022|

LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients

VIEW PUBLICATION ⟶

June 4th, 2022|

Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?

VIEW PUBLICATION ⟶

May 30th, 2022|

Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myeloma

VIEW PUBLICATION ⟶

May 3rd, 2022|

Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients

VIEW PUBLICATION ⟶

January 4th, 2022|

NGS Analysis of Clonality and Minimal Residual Disease in a Patient with Concurrent Richter’s Transformation and CLL/SLL

VIEW PUBLICATION ⟶

December 28th, 2021|

Plan for a Successful International Drug Approval with Early Development of the Accompanying CDx

VIEW PUBLICATION ⟶

December 8th, 2021|

Machine Learning Algorithms Accelerate Throughput of a Flow – Sequencing Cell Based Assay for an Acute Myeloid Leukemia (AML) Therapeutic Discovery Platform

VIEW PUBLICATION ⟶

November 5th, 2021|

Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing

VIEW PUBLICATION ⟶

June 24th, 2021|

Feasibility of cell-free DNA collection and clonal immunoglobulin sequencing in South African patients with HIV-associated lymphoma

VIEW PUBLICATION ⟶

April 28th, 2021|

Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

VIEW PUBLICATION ⟶

April 20th, 2021|

Validation and interpretation of IGH and TCR clonality testing by Ion Torrent S5 NGS for diagnosis and disease monitoring in B and T cell cancers

VIEW PUBLICATION ⟶

November 25th, 2020|

Classification of intestinal T‐cell receptor repertoires using machine learning methods can identify patients with coeliac disease regardless of dietary gluten status

VIEW PUBLICATION ⟶

November 22nd, 2020|

Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

VIEW PUBLICATION ⟶

November 17th, 2020|

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

VIEW PUBLICATION ⟶

October 30th, 2020|

Plasticity of the human IgM repertoire in response to long‐term spaceflight

VIEW PUBLICATION ⟶

October 13th, 2020|

Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy

VIEW PUBLICATION ⟶

October 8th, 2020|

Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype

VIEW PUBLICATION ⟶

August 27th, 2020|

Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment

VIEW PUBLICATION ⟶

July 22nd, 2020|

Evaluation of the polymerase chain reaction–based T-cell receptor β clonality test in the diagnosis of early mycosis fungoides

VIEW PUBLICATION ⟶

June 8th, 2020|

Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing

VIEW PUBLICATION ⟶

May 19th, 2020|

Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment

VIEW PUBLICATION ⟶

May 6th, 2020|

Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma

VIEW PUBLICATION ⟶

May 1st, 2020|

Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV status

VIEW PUBLICATION ⟶

April 1st, 2020|

Quantitation of CMV Specific T-Cell Expansion Using T Cell Receptor Beta Locus Deep Sequencing to Identify Patients at Risk of Viral Complications

VIEW PUBLICATION ⟶

March 1st, 2020|

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

VIEW PUBLICATION ⟶

February 6th, 2020|

Monitoring minimal residual disease in the bone marrow using next generation sequencing

VIEW PUBLICATION ⟶

January 17th, 2020|

Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a “Spike-in” Clonal Sequence

VIEW PUBLICATION ⟶

November 13th, 2019|

Clonally-Related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implications

VIEW PUBLICATION ⟶

October 15th, 2019|

Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma

VIEW PUBLICATION ⟶

October 1st, 2019|

Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma

VIEW PUBLICATION ⟶

June 6th, 2019|

Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms

VIEW PUBLICATION ⟶

March 21st, 2019|

A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations

VIEW PUBLICATION ⟶

August 25th, 2018|

Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL

VIEW PUBLICATION ⟶

August 22nd, 2018|

Clinical-scale Rapid Autologous BK-virus Specific T Cell Line generation from Kidney Transplant Recipients with Active Viremia for Adoptive Immunotherapy

VIEW PUBLICATION ⟶

November 11th, 2017|

Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)

VIEW PUBLICATION ⟶

August 9th, 2017|

Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia

VIEW PUBLICATION ⟶

July 3rd, 2017|

In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis

VIEW PUBLICATION ⟶

June 20th, 2017|

Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients

VIEW PUBLICATION ⟶

June 17th, 2017|

T and B cell clonal expansion in Ras associated lymphoproliferative disease (RALD) as revealed by next generation sequencing

VIEW PUBLICATION ⟶

May 30th, 2017|

Molecular pathology diagnosis of diffuse large B cell lymphoma using BIOMED-2 clonal gene rearrangements

VIEW PUBLICATION ⟶

April 27th, 2017|

A Small Case Series of Intravascular Large B-Cell Lymphoma with Unexpected Findings: Subset of Cases with Concomitant Extravascular Central Nervous System (CNS) Involvement Mimicking Primary CNS Lymphoma

VIEW PUBLICATION ⟶

April 17th, 2017|

Targeted Deep Sequencing Reveals Clinically Relevant Subclonal IgHV Rearrangements in Chronic Lymphocytic Leukemia

VIEW PUBLICATION ⟶

October 31st, 2016|

Breast Implant-Associated Anaplastic Large Cell Lymphoma: Two Distinct Clinicopathological Variants with Different Outcomes

VIEW PUBLICATION ⟶

February 1st, 2016|

Discordant Lymphoma Consisting of Mediastinal Large B-Cell Lymphoma and Nodular Sclerosis Hodgkin Lymphoma in the Right Supraclavicular Lymph Nodes: A Case Report

VIEW PUBLICATION ⟶

December 29th, 2015|

Molecular Genetic Data Favoring a Sequential Clonal Transformation of a Large B Cell Lymphoma into an Anaplastic Large T Cell Lymphoma, ALK-Negative

VIEW PUBLICATION ⟶

December 1st, 2015|

Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder Arising in the Oral Cavity Following Dental Implants

VIEW PUBLICATION ⟶

August 10th, 2015|

Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia

VIEW PUBLICATION ⟶

March 18th, 2015|

Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas

VIEW PUBLICATION ⟶

August 15th, 2014|

Immunoblastic Follicular Lymphoma: A Very Unusual Transformation of Low-Grade Follicular Lymphoma

VIEW PUBLICATION ⟶

August 13th, 2014|

The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies

VIEW PUBLICATION ⟶

April 5th, 2014|

Clonality Of Multiple Distinct Lymphoproliferative Disorders Occurring Within Individual HIV+ Patients

VIEW PUBLICATION ⟶

November 15th, 2013|

Hydroa Vacciniforme-like Lymphoma: A Chronic EBV+ Lymphoproliferative Disorder with Risk to Develop a Systemic Lymphoma

VIEW PUBLICATION ⟶

October 31st, 2013|

Paediatric and Adolescent Elevated Conjunctival Lesions in the Plical Area: Lymphoma or Reactive Lymphoid Hyperplasia?

VIEW PUBLICATION ⟶

October 25th, 2013|

Diagnostic Utility of a Clonality Test for Lymphoproliferative Diseases in Koreans Using the BIOMED-2 PCR Assay

VIEW PUBLICATION ⟶

October 25th, 2013|

Dried Blood Spot Sampling for Detection of Monoclonal Immunoglobulin Gene Rearrangement

VIEW PUBLICATION ⟶

August 13th, 2013|

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

VIEW PUBLICATION ⟶

October 26th, 2012|

A Practical Approach to Diagnostic Ig/TCR Clonality Evaluation in Clinical Pathology

VIEW PUBLICATION ⟶

January 11th, 2012|

Multiple Clonal Ig/TCR Products: Implications for Interpretation of Clonality Findings

VIEW PUBLICATION ⟶

December 10th, 2011|

Application of cost–effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemia

VIEW PUBLICATION ⟶

March 30th, 2011|

Molecular Diagnostics of Hematologic Malignancies

VIEW PUBLICATION ⟶

September 2nd, 2009|

IMGT/GeneInfo: T cell receptor gamma TRG and delta TRD genes in database give access to all TR potential V(D)J recombinations

VIEW PUBLICATION ⟶

April 26th, 2006|

IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V–J and V–D–J JUNCTIONs

VIEW PUBLICATION ⟶

August 4th, 2004|

ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid Leukemia

VIEW PUBLICATION ⟶

June 3rd, 2026|

NGS-based MRD monitoring in mature B-cell and plasma cell malignancies. Academia Molecular Biology & Genomics

VIEW PUBLICATION ⟶

May 28th, 2026|

T-cell receptor gamma (TRG) diversity predicts peripheral blood involvement in primary cutaneous T-cell lymphoma

VIEW PUBLICATION ⟶

March 5th, 2026|

Ultrasensitive next-generation sequencing-based clonality assay for disease monitoring in B-cell acute lymphoblastic leukaemia

VIEW PUBLICATION ⟶

February 20th, 2026|

Measurable Residual Disease detection in acute lymphoblastic leukaemia: comparison between targeted NGS and ASO-RQPCR

VIEW PUBLICATION ⟶

January 23rd, 2026|

Measurable residual disease monitoring after hematopoietic stem cell transplantation

VIEW PUBLICATION ⟶

December 30th, 2025|

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia

VIEW PUBLICATION ⟶

November 24th, 2025|

QuANTUM-First: Clinical Validation of the LeukoStrat Companion Diagnostic for the Selection of Patients With Acute Myeloid Leukemia Harboring FMS-Like Tyrosine Kinase 3–Internal Tandem Duplications for Treatment With Quizartinib

VIEW PUBLICATION ⟶

September 3rd, 2025|

A Systematic, Evidence-Based Workflow for Classifying KMT2A Fusions in AML

VIEW PUBLICATION ⟶

July 29th, 2025|

Performance Comparison of Illumina® MiSeq™ and MiSeq™ i100 Systems using Invivoscribe’s LymphoTrack® Assays

VIEW WHITE PAPER ⟶

May 27th, 2025|

From prognostication to precision in acute myeloid leukemia

VIEW PUBLICATION ⟶

May 8th, 2025|

Measurable residual disease and post-transplantation gilteritinib maintenance for patients with FLT3 ITD mutated AML

VIEW PUBLICATION ⟶

May 8th, 2025|

Comparison of Complete Genomics DNBSEQ-G99 Sequencer and Illumina® MiSeqTM using Invivoscribe’s FLT3 ITD MRD Assay and NPM1 MRD Assay

VIEW WHITE PAPER ⟶

November 8th, 2024|

Performance Comparison of Invivoscribe’s LymphoTrack® Assays Between Complete Genomics DNBSEQ-G99 and Illumina® MiSeqTM NGS Platforms

VIEW WHITE PAPER ⟶

November 8th, 2024|

Clonality and Measurable Residual Disease (MRD) Testing on the Illumina NextSeq Sequencers

VIEW WHITE PAPER ⟶

June 21st, 2024|

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

VIEW PUBLICATION ⟶

May 2nd, 2024|

Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing

VIEW PUBLICATION ⟶

March 20th, 2024|

Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal residual disease detection in Chinese patients with multiple myeloma

VIEW PUBLICATION ⟶

March 19th, 2024|

Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing–Based Clonality Testing in B-Cell and Plasma Cell Neoplasms

VIEW PUBLICATION ⟶

March 1st, 2024|

Leveraging Standardized MRD Assays to Guide CLL Treatment

VIEW PUBLICATION ⟶

January 25th, 2024|

Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

VIEW PUBLICATION ⟶

March 23rd, 2023|

DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant

VIEW PUBLICATION ⟶

March 7th, 2023|

Minimal/Measurable Residual Disease (MRD) Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor

VIEW PUBLICATION ⟶

March 2nd, 2023|

Comparing Data Generated Using Multiparametric Flow Cytometry, Capillary Electrophoresis, and Next-Generation Sequencing in a Cohort of B-Cell Lymphoproliferative Disorder Samples

VIEW PUBLICATION ⟶

November 15th, 2022|

LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients

VIEW PUBLICATION ⟶

June 4th, 2022|

Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?

VIEW PUBLICATION ⟶

May 30th, 2022|

Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myeloma

VIEW PUBLICATION ⟶

May 3rd, 2022|

Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients

VIEW PUBLICATION ⟶

January 4th, 2022|

Feasibility of cell-free DNA collection and clonal immunoglobulin sequencing in South African patients with HIV-associated lymphoma

VIEW PUBLICATION ⟶

April 28th, 2021|

NGS Analysis of Clonality and Minimal Residual Disease in a Patient with Concurrent Richter’s Transformation and CLL/SLL

VIEW PUBLICATION ⟶

December 28th, 2021|

Plan for a Successful International Drug Approval with Early Development of the Accompanying CDx

VIEW PUBLICATION ⟶

December 8th, 2021|

Machine Learning Algorithms Accelerate Throughput of a Flow – Sequencing Cell Based Assay for an Acute Myeloid Leukemia (AML) Therapeutic Discovery Platform

VIEW PUBLICATION ⟶

November 5th, 2021|

Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing

VIEW PUBLICATION ⟶

June 24th, 2021|

Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

VIEW PUBLICATION ⟶

April 20th, 2021|

Validation and interpretation of IGH and TCR clonality testing by Ion Torrent S5 NGS for diagnosis and disease monitoring in B and T cell cancers

VIEW PUBLICATION ⟶

November 25th, 2020|

Classification of intestinal T‐cell receptor repertoires using machine learning methods can identify patients with coeliac disease regardless of dietary gluten status

VIEW PUBLICATION ⟶

November 22nd, 2020|

Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

VIEW PUBLICATION ⟶

November 17th, 2020|

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

VIEW PUBLICATION ⟶

October 30th, 2020|

Plasticity of the human IgM repertoire in response to long‐term spaceflight

VIEW PUBLICATION ⟶

October 13th, 2020|

Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy

VIEW PUBLICATION ⟶

October 8th, 2020|

Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype

VIEW PUBLICATION ⟶

August 27th, 2020|

Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment

VIEW PUBLICATION ⟶

July 22nd, 2020|

Evaluation of the polymerase chain reaction–based T-cell receptor β clonality test in the diagnosis of early mycosis fungoides

VIEW PUBLICATION ⟶

June 8th, 2020|

Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing

VIEW PUBLICATION ⟶

May 19th, 2020|

Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment

VIEW PUBLICATION ⟶

May 6th, 2020|

Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma

VIEW PUBLICATION ⟶

May 1st, 2020|

Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV status

VIEW PUBLICATION ⟶

April 1st, 2020|

Quantitation of CMV Specific T-Cell Expansion Using T Cell Receptor Beta Locus Deep Sequencing to Identify Patients at Risk of Viral Complications

VIEW PUBLICATION ⟶

March 1st, 2020|

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

VIEW PUBLICATION ⟶

February 6th, 2020|

Monitoring minimal residual disease in the bone marrow using next generation sequencing

VIEW PUBLICATION ⟶

January 17th, 2020|

Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a “Spike-in” Clonal Sequence

VIEW PUBLICATION ⟶

November 13th, 2019|

Clonally-Related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implications

VIEW PUBLICATION ⟶

October 15th, 2019|

Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma

VIEW PUBLICATION ⟶

October 1st, 2019|

Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma

VIEW PUBLICATION ⟶

June 6th, 2019|

Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms

VIEW PUBLICATION ⟶

March 21st, 2019|

A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations

VIEW PUBLICATION ⟶

August 25th, 2018|

Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL

VIEW PUBLICATION ⟶

August 22nd, 2018|

Clinical-scale Rapid Autologous BK-virus Specific T Cell Line generation from Kidney Transplant Recipients with Active Viremia for Adoptive Immunotherapy

VIEW PUBLICATION ⟶

November 11th, 2017|

Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)

VIEW PUBLICATION ⟶

August 9th, 2017|

Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia

VIEW PUBLICATION ⟶

July 3rd, 2017|

In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis

VIEW PUBLICATION ⟶

June 20th, 2017|

Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients

VIEW PUBLICATION ⟶

June 17th, 2017|

T and B cell clonal expansion in Ras associated lymphoproliferative disease (RALD) as revealed by next generation sequencing

VIEW PUBLICATION ⟶

May 30th, 2017|

Molecular pathology diagnosis of diffuse large B cell lymphoma using BIOMED-2 clonal gene rearrangements

VIEW PUBLICATION ⟶

April 27th, 2017|

A Small Case Series of Intravascular Large B-Cell Lymphoma with Unexpected Findings: Subset of Cases with Concomitant Extravascular Central Nervous System (CNS) Involvement Mimicking Primary CNS Lymphoma

VIEW PUBLICATION ⟶

April 17th, 2017|

Targeted Deep Sequencing Reveals Clinically Relevant Subclonal IgHV Rearrangements in Chronic Lymphocytic Leukemia

VIEW PUBLICATION ⟶

October 31st, 2016|

Breast Implant-Associated Anaplastic Large Cell Lymphoma: Two Distinct Clinicopathological Variants with Different Outcomes

VIEW PUBLICATION ⟶

February 1st, 2016|
Archived Publications

Discordant Lymphoma Consisting of Mediastinal Large B-Cell Lymphoma and Nodular Sclerosis Hodgkin Lymphoma in the Right Supraclavicular Lymph Nodes: A Case Report

VIEW PUBLICATION ⟶

December 29th, 2015|

Molecular Genetic Data Favoring a Sequential Clonal Transformation of a Large B Cell Lymphoma into an Anaplastic Large T Cell Lymphoma, ALK-Negative

VIEW PUBLICATION ⟶

December 1st, 2015|

Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder Arising in the Oral Cavity Following Dental Implants

VIEW PUBLICATION ⟶

August 10th, 2015|

Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia

VIEW PUBLICATION ⟶

March 18th, 2015|

Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas

VIEW PUBLICATION ⟶

August 15th, 2014|

Immunoblastic Follicular Lymphoma: A Very Unusual Transformation of Low-Grade Follicular Lymphoma

VIEW PUBLICATION ⟶

August 13th, 2014|

The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies

VIEW PUBLICATION ⟶

April 5th, 2014|

Clonality Of Multiple Distinct Lymphoproliferative Disorders Occurring Within Individual HIV+ Patients

VIEW PUBLICATION ⟶

November 15th, 2013|

Hydroa Vacciniforme-like Lymphoma: A Chronic EBV+ Lymphoproliferative Disorder with Risk to Develop a Systemic Lymphoma

VIEW PUBLICATION ⟶

October 31st, 2013|

Paediatric and Adolescent Elevated Conjunctival Lesions in the Plical Area: Lymphoma or Reactive Lymphoid Hyperplasia?

VIEW PUBLICATION ⟶

October 25th, 2013|

Diagnostic Utility of a Clonality Test for Lymphoproliferative Diseases in Koreans Using the BIOMED-2 PCR Assay

VIEW PUBLICATION ⟶

October 25th, 2013|

Dried Blood Spot Sampling for Detection of Monoclonal Immunoglobulin Gene Rearrangement

VIEW PUBLICATION ⟶

August 13th, 2013|

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

VIEW PUBLICATION ⟶

October 26th, 2012|

A Practical Approach to Diagnostic Ig/TCR Clonality Evaluation in Clinical Pathology

VIEW PUBLICATION ⟶

January 11th, 2012|

Multiple Clonal Ig/TCR Products: Implications for Interpretation of Clonality Findings

VIEW PUBLICATION ⟶

December 10th, 2011|

Application of cost–effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemia

VIEW PUBLICATION ⟶

March 30th, 2011|

Molecular Diagnostics of Hematologic Malignancies

VIEW PUBLICATION ⟶

September 2nd, 2009|

IMGT/GeneInfo: T cell receptor gamma TRG and delta TRD genes in database give access to all TR potential V(D)J recombinations

VIEW PUBLICATION ⟶

April 26th, 2006|

IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V–J and V–D–J JUNCTIONs

VIEW PUBLICATION ⟶

August 4th, 2004|

© 2018 -    |   Invivoscribe, Inc. |   All Rights Reserved